Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study

por Guo, Yanling, Zhu, Yaoyao, Zhang, Ran, Yang, Shuangyan, Kepka, Lucyna, Viani, Gustavo Arruda, Milano, Michael T., Sio, Terence T., Sun, Xiaojiang, Wu, Hongyu, Xing, Ligang, Xu, Yaping
Publicado 2023

Patient-led advocacy in ALK-positive lung cancer

por Barton, Colin, Al Achkar, Morhaf, Blender, Jennifer A., Farmen, Summer Hall, Hall, Raymond B., Konidari, Afroditi Maria, Martinez, Debbi, Pronsati, Nancee, Rosenzweig, Marc, Vass, Carla, Venanzi, Emily S., Westlake, William, Muskavitch, Marc A. T.
Publicado 2023

Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors

por Arasanz, Hugo, Morilla, Idoia, Martínez-Aguillo, Maite, Teijeira, Lucía, Vera, Ruth, Alsina, Maria
Publicado 2023

KRAS G12C mutation: from undruggable target to potentially agnostic biomarker

por El Osta, Badi
Publicado 2023

Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)

por Araki, Taisuke, Kanda, Shintaro, Komatsu, Masamichi, Sonehara, Kei, Tateishi, Kazunari, Takada, Munetake, Kato, Akane, Yamamoto, Manabu, Nishie, Kenichi, Hama, Mineyuki, Agatsuma, Toshihiko, Kakizaki, Yumiko, Yoshiike, Fumiaki, Matsuo, Akemi, Chiaki, Tomoshige, Samizo, Kanae, Takagi, Yoshiko, Yamaura, Maki, Hanaoka, Masayuki, Koizumi, Tomonobu
Publicado 2023

Concordance between cryobiopsy and forceps biopsy specimens in assessment of immunohistochemistry staining for non-small cell lung carcinoma

por Nishimatsu, Kanako, Matsumoto, Yuji, Kashima, Jumpei, Imabayashi, Tatsuya, Uchimura, Keigo, Furuse, Hideaki, Masuda, Ken, Shinno, Yuki, Okuma, Yusuke, Yoshida, Tatsuya, Goto, Yasushi, Horinouchi, Hidehito, Yamamoto, Noboru, Tsuchida, Takaaki, Ohe, Yuichiro, Yatabe, Yasushi
Publicado 2023

CLOCK’ing differences in DNA methylation signatures to understand the molecular etiology of lung cancer

por Neely, Aaron M., Yang, Minxiao, Marconett, Crystal N.
Publicado 2023

Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR(+) non-small-cell lung cancer

por Nishio, Makoto, Atagi, Shinji, Goto, Koichi, Hosomi, Yukio, Seto, Takashi, Hida, Toyoaki, Nakagawa, Kazuhiko, Yoshioka, Hiroshige, Nogami, Naoyuki, Maemondo, Makoto, Nagase, Seisuke, Okamoto, Isamu, Yamamoto, Noboru, Igawa, Yuriko, Tajima, Kosei, Fukuoka, Masahiro, Yamamoto, Nobuyuki, Nishio, Kazuto
Publicado 2023

Quantitative spatial profiling of PD-1/PD-L1 interaction in patients with cancer

por Hakozaki, Taiki
Publicado 2023

Intracranial responses with selective KRAS-G12C inhibitors in non-small cell lung cancer

por Lu, Kevin, Husain, Hatim
Publicado 2023

Tarlatamab: the promising immunotherapy on its way from the lab to the clinic

por Tang, Daolin, Kang, Rui
Publicado 2023

Clinical applications of DNA methylation profiling in lung cancer

por Castro-Gonzalez, Sergio, Cuadros, Marta, Medina, Pedro P.
Publicado 2023

High NHLRC2 expression is associated with shortened survival in lung adenocarcinoma

por Kreus, Mervi A., Lehtonen, Siri T., Mäkinen, Johanna M., Lappi-Blanco, H. Elisa, Laitakari, Kirsi E. M., Johnson, Shirley A., Hinttala, Reetta M. L., Kaarteenaho, Riitta L.
Publicado 2023

LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer

por Sattler, Martin, Salgia, Ravi
Publicado 2023

Uniportal video-assisted thoracic surgery segmentectomy: a promising new development for thoracic surgery

por Forster, Céline, Gonzalez, Michel
Publicado 2023

Uniportal versus multiportal VATS segmentectomy: less is more?

por van Roozendaal, Lori M., Daemen, Jean H. T., Franssen, Aimée J. P. M., Hulsewé, Karel W. E., Vissers, Yvonne L. J., de Loos, Erik R.
Publicado 2023

A pilot study of anlotinib with third-generation epidermal growth factor receptor tyrosine kinase inhibitors in untreated EGFR-mutant patients with advanced non-small cell lung can...

por Li, Ting, Chang, Kejie, Qiu, Xin, Lai, Zhirong, Luo, Yuanling, Chen, Jiaqun, Lv, Weize, Lin, Zhong, Pei, Xiaofeng, Wu, Xiangwen, Wang, Xiaojin
Publicado 2023

Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer

por Patel, Krishna H., Alpert, Naomi, Tuminello, Stephanie, Taioli, Emanuela
Publicado 2023

Treatment options and prognosis of patients with lung squamous cell cancer in situ: a comparative study of lung adenocarcinoma in situ and stage IA lung squamous cell cancer

por Zhang, Kaixuan, Chen, Hao, Jiang, Yan, Chen, Qiankun, Su, Bo, Zhou, Xiao
Publicado 2023

Follow-up regimen after lung cancer treatment: about the how and why

por Heuvelmans, Marjolein A., De Bock, Geertruida H.
Publicado 2023